Jordi Guardiola

Bellvitge University Hospital

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Collaborators (6)

marine camus

Associate Professor

Sorbonne Université

FRANCE

View details

Manuel Barreiro de Acosta

Profesor Asociado

Universidade de Santiago de Compostela

SPAIN

View details

Vicente Lorenzo-Zúñiga

Profesor Asociado de Medicina y Cirugía del Aparato Digestivo

Universidad Católica de Valencia San Vicente Mártir

SPAIN

View details

Angel Ponferrada

Profesor Asociado

Universidad Complutense de Madrid

SPAIN

View details

Pilar Nos

Head

Hospital Universitari i Politècnic La Fe

SPAIN

View details

FRANCISCO RODRIGUEZ MORANTA

Bellvitge University Hospital

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jordi Guardiola

Research Interests

Explore related searches

Contact this professor

Articles (10)

Frequency and Effectiveness of Dose Escalation and De-Escalation of Biologic Therapy in Inflammatory Bowel Disease: The RAINBOW-IBD Study of ENEIDA.

Influence of Familial Inflammatory Bowel Disease History on the Use of Immunosuppressants, Biological Agents and Surgery in Patients with Pediatric-Onset of the Disease in the Era of Biological Therapies. Results from the ENEIDA Registry

New insights into thiopurine toxicity: The contribution of rare XDH variants to myelotoxicity

Prevention of Tuberculosis in Patients Treated With Biological Therapies: 20 Years' Experience in a Specialized Tuberculosis Clinic in a Low-prevalence Country

Defining partial response in inflammatory bowel disease: a Delphi consensus and economic evaluation

Long‐Term Outcomes Following Withdrawal of Anti‐Tumour Necrosis Factor Treatment in Inflammatory Bowel Disease Patients in Remission: The Exit Long‐Term Study of GETECCU

Prospective and multicenter study on clinical-biological factors predictive of chronic colon diverticulitis: DICRO Trial

In-hospital Mortality in Patients with Lower Gastrointestinal Bleeding: Development and Validation of a Prediction Score.

Faecal calprotectin-based strategy for long-term monitoring of patients with Crohn's disease without or with mild endoscopic postoperative recurrence.

Persistence, Effectiveness, and Safety of Upadacitinib in Crohn's Disease and Ulcerative Colitis in Real Life: Results From a Spanish Nationwide Study (Ureal Study).

Collaborators (6)

marine camus

Manuel Barreiro de Acosta

Vicente Lorenzo-Zúñiga

Angel Ponferrada

Pilar Nos

FRANCISCO RODRIGUEZ MORANTA

Make your next move.